Table 1: Baseline characteristics of patients affected by COVID-19 pneumonia divided by type of received treatment.
|
Total (n = 423) |
G1 (n = 135) |
G2 (n = 8) |
G3 (n = 214) |
G4 (n = 66) |
P |
Age (years) |
71 (59-80) |
68 (57-77)* |
74 (66-82) |
70 (59-80) |
78 (69-84)* |
< 0.001 |
Sex (male) (n, %) |
276 (65.2%) |
91 (67.4) |
6 (75.0) |
132 (61.7) |
47 (71.2) |
0.42 |
BMI (Kg/m2) |
26.4 (23.9-30.3) |
26.1 (23.8-30.1) |
28.4 (24.2-30.2) |
26.8 (23.8-30.3) |
26.2 (24.3-31.2) |
0.86 |
Obesity (BMI > 30 Kg/m2) (n, %) |
73 (17.3%) |
21 (15.6) |
2 (25.0) |
34 (15.9) |
16 (24.2) |
0.37 |
Charlson index |
4 (2-6) |
3 (1-5)* |
5 (4-7) |
4 (2-6)§ |
5 (4-8)*§ |
< 0.001 |
Comorbidities (n, %): · Hypertension · CVD# · DM · Neoplasia · COPD · Asthma · Hepatic disease · CKD |
222 (52.5) 82 (19.4) 86 (20.3) 61 (14.4) 50 (11.8) 16 (3.8) 5 (1.2) 38 (9.0) |
71 (52.6) 25 (18.5) 21 (15.6) 14 (10.3) 13 (9.6) 5 (3.7) 0 (0) 11 (8.1) |
5 (62.5) 1 (12.5) 1 (12.5) 2 (25.0) 1 (12.5) 0 (0) 0 (0) 0 (0) |
107 (50.0) 36 (16.8) 50 (23.4) 23 (13.1) 20 (9.3) 6 (2.8) 3 (1.4) 19 (8.9) |
39 (59.1) 20 (30.3) 14 (21.2) 17 (25.8) 16 (24.2) 5 (7.6) 3 (3.0) 8 (12.1) |
0.57 0.10 0.65 0.02 0.01 0.32 0.29 0.63 |
Smoke (n, %) |
50 (11.8) |
13 (9.6) |
0 (0) |
25 (11.7) |
12 (18.2) |
0.24 |
Heart rate (bpm) |
80 (74-90) |
84 (76-95) |
73 (70-89) |
80 (72-90) |
80 (71-90) |
0.13 |
RR (breath per minute) |
22 (20-26) |
22 (19-28) |
23 (19-25) |
22 (20-26) |
22 (20-26) |
0.55 |
Fever (n, %) |
273 (64.5) |
69 (51.1)* |
4 (50) |
148 (69.2)§ |
52 (78.8)*§ |
< 0.001 |
Temperature (°C) |
38.0 (37.2-38.7) |
37.8 (37.1-38.6) |
37.6 (26.8-38.3) |
38.0 (37.2-38.7) |
38.0 (37.2-38.7) |
0.80 |
SOFA score |
1 (1-2) |
1 (1-2) |
2 (1-3) |
1 (1-2) |
2 (1-2) |
0.06 |
SpO2/FiO2 ratio at the admission |
296 (175-442) |
312 (149-442)* |
342 (138-442) |
328 (245-447)§ |
228 (123-310)*§ |
< 0.001 |
Lowest peak of SpO2/FiO2 ratio |
201 (97-332) |
211 (94-339)* |
97 (88-208) |
237 (104-235)§ |
100 (94-179)*§ |
< 0.001 |
Onset of symptoms (days) |
7 (4-10) |
7 (5-10)^ |
4 (3-5)^** |
7 (4-10)** |
6 (4-10) |
0.02 |
Oxygen support (n, %) |
347 (82) |
97 (71.9)*° |
6 (75.0) |
178 (83.6)°§ |
66 (98.5)*§ |
< 0.001 |
Day from hospitalization to treatment |
1 (0-3) |
/ |
3 (1-6) |
0 (0-1)§ |
3 (1-6)§ |
< 0.001 |
Day from hospitalization to climax |
2 (0-5) |
2 (0-4)* |
5 (1-10) |
2 (1-4)§ |
5 (2-8)*§ |
< 0.001 |
ICU with mechanical ventilation (n, %) |
64 (15.1) |
40 (29.6)*° |
1 (12.5) |
16 (7.5)° |
7 (10.6)* |
< 0.001 |
Death for all causes (n, %) |
87 (20.6) |
24 (17.8)* |
4 (50.0) |
38 (17.7)§ |
21 (31.8)*§ |
0.01 |
Treatment failure (n, %) |
151 (35.7) |
64 (47.4)° |
5 (62.5) |
54 (25.2)°§ |
28 (42.4)§ |
< 0.001 |
Data are expressed as median ۧ interquartile range (IQR) when not specified.
#CVD included acute coronary syndrome, chronic heart failure, arrhythmias.
*Significant difference between G1 and G4; §Significant difference between G3 and G4; ^Significant difference between G1 and G2; **Significant difference between G2 and G3; °Significant difference between G1 and G3
Abbreviations: BMI: Body mass index; CVD: Cardiovascular disease; DM: Diabetes mellitus; COPD: Chronic obstructive pulmonary disease; CKD: Chronic kidney disease; RR: Respiratory rate; SOFA: Sequential organ failure assessment; SpO2/FiO2: Oxygen saturation to fraction of inspired oxygen ratio; ICU: Intensive care unit.